Identification of cancer stem cells and a strategy for their elimination

Cancer Biology and Therapy

Volumn 15, Issue 10, 2014, Pages 1378-1394

  Dolgova, Evgenia V ^a   Alyamkina, Ekaterina A ^a   Efremov, Yaroslav R ^a,b   Nikolin, Valeriy P ^a   Popova, Nelly A ^a,b   Tyrinova, Tamara V ^c   Kozel, Artem V ^b   Minkevich, Alexandra M ^b   Andrushkevich, Oleg M ^b   Zavyalov, Evgeniy L ^a   Romaschenko, Alexander V ^a   Bayborodin, Sergey I ^a,b   Taranov, Oleg S ^d   Omigov, Vladimir V ^d   Shevela, Ekaterina Ya ^c   Stupak, Vyacheslav V ^e   Mishinov, Sergey V ^e   Rogachev, Vladimir A ^a   Proskurina, Anastasia S ^a   Mayorov, Vladimir I ^f   Shurdov, Mikhail A ^g   Ostanin, Alexander A ^c   Chernykh, Elena R ^c   Bogachev, Sergey S ^a   more..

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

^c INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

^d STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^e NOVOSIBIRSK RESEARCH INSTITUTE OF TRAUMATOLOGY AND ORTHOPAEDICS N A YA L TSIVYAN   (Russian Federation)

^f MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g LLC Panagen ^*  (Russian Federation)

Author keywords

Ascites form of Krebs 2 tumor; Cyclophosphamide; Human glioma neurosphere; TAMRA labeled DNA; Tumor initiating stem cells

Indexed keywords

CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA; ANTINEOPLASTIC AGENT; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES CELL; CANCER STEM CELL; CARCINOGENICITY; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; KIDNEY CARCINOMA; MAMMAL CELL; MOUSE; NONHUMAN; PHENOTYPE; ANIMAL; APOPTOSIS; ASCITES; BRAIN TUMOR; CARCINOMA; CBA MOUSE; DRUG EFFECTS; ENDOCYTOSIS; GENETICS; GLIOBLASTOMA; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; RECOMBINATION REPAIR; SCID MOUSE; TUMOR CELL CULTURE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASCITES; BRAIN NEOPLASMS; CARCINOMA, KREBS 2; CELL PROLIFERATION; CYCLOPHOSPHAMIDE; DNA; ENDOCYTOSIS; GLIOBLASTOMA; HETEROGRAFTS; MICE, INBRED CBA; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; RECOMBINATIONAL DNA REPAIR; TUMOR CELLS, CULTURED;

EID: 84908450235     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.29854     Document Type: Article

References (34)

1. Dick JE Stem cells: Self-renewal writ in blood. Nature 2003; 423: 231-3; PMID: 12748623; http://dx.doi.org/10.1038/423231a
2. Dick JE Breast cancer stem cells revealed. Proc Natl Acad Sci U S A 2003; 100: 3547-9; PMID: 12657737; http://dx.doi.org/10.1073/pnas.0830967100
3. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004; 23: 7274-82; PMID: 15378087; http://dx.doi.org/10.1038/sj.onc.1207947
4. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-44; PMID: 16990346; http://dx.doi.org/10.1158/0008-5472.CAN-06-3126
5. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-8; PMID: 7509044; http://dx.doi.org/10.1038/367645a0
6. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-7; PMID: 9212098; http://dx.doi.org/10.1038/nm0797-730
7. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009; 347: 70-8; PMID: 19567251; http://dx.doi.org/10.1016/j.jim.2009.06.008
8. Frisan T, Levitsky V, Masucci M. Limiting dilution assay. Methods Mol Biol 2001; 174: 213-6; PMID: 11357647
9. Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, et al. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol 2011; 11: 71; PMID: 21669008; http://dx.doi.org/10.1186/1471-230X-11-71
10. Rajasekhar VK Analytical methods for cancer stem cells. Methods Mol Biol 2007; 407: 83-95; PMID: 18453250; http://dx.doi.org/10.1007/978-1-59745-536-7-7
11. O'Brien CA, Kreso A, Jamieson CH. Cancer stem cells and self-renewal. Clin Cancer Res 2010; 16: 3113-20; PMID: 20530701; http://dx.doi.org/10.1158/1078-0432.CCR-09-2824
12. Zhang W, Kai K, Choi DS, Iwamoto T, Nguyen YH, Wong H, Landis MD, Ueno NT, Chang J, Qin L. Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cells. Proc Natl Acad Sci U S A 2012; 109: 18707-12; PMID: 23112172; http://dx.doi.org/10.1073/pnas.1209893109
13. Lu J, Cui Y, Zhu J, He J, Zhou G, Yue Z. Biological characteristics of Rh123(high) stem-like cells in a side population of 786-O renal carcinoma cells. Oncol Lett 2013; 5: 1903-8; PMID: 23833664
14. Oates JE, Grey BR, Addla SK, Samuel JD, Hart CA, Ramani VA, Brown MD, Clarke NW. Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers. Stem Cells Dev 2009; 18: 1515-22; PMID: 19260804; http://dx.doi.org/10.1089/scd.2008.0302
15. Dolgova EV, Proskurina AS, Nikolin V P, Popova NA, Alyamkina EA, Orishchenko KE, Rogachev VA, Efremov YR, Dubatolova TD, Prokopenko AV, et al. "Delayed death" phenomenon: a synergistic action of cyclophosphamide and exogenous DNA. Gene 2012; 495: 134-45; PMID: 22227496; http://dx.doi.org/10.1016/j.gene.2011.12.032
16. + hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA. Gene 2013; 528: 74-83; PMID: 23911305; http://dx.doi.org/10.1016/j.gene.2013.06.058
17. Likhacheva AS, Nikolin V P, Popova NA, Dubatolova TD, Strunkin DN, Rogachev VA, Sebeleva TE, Erofeev IS, Bogachev SS, Yakubov LA, et al. Integration of human DNA fragments into the cell genomes of certain tissues from adult mice treated with cytostatic cyclophosphamide in combination with human DNA. Gene Ther Mol Biol 2007; 11: 185-202
18. Alyamkina EA, Dolgova EV, Likhacheva AS, Rogachev VA, Sebeleva TE, Nikolin V P, Popova NA, Orishchenko KE, Strunkin DN, Chernykh ER, et al. Combined therapy with cyclophosped hamide and DNA preparation inhibits the tumor growth in mice. Genet Vaccines Ther 2009; 7: 12; http://www.gvt-journal.com/content/7/1/12; PMID: 19682353; http://dx.doi.org/10.1186/1479-0556-7-12.
19. Nikolin V P, Popova NA, Sebeleva TE, Strunkin DN, Rogachev VA, Semenov DV, Bogachev SS, Iakubov LA, Shurdov MA. [Effect of exogenous dna injection on leukopoietic repair and antitumor action of cyclophosphamide] [In Russian]. Vopr Onkol 2006; 52: 336-40; PMID: 17191708
20. Ermakov AV, Konkova MS, Kostyuk SV, Smirnova TD, Malinovskaya EM, Efremova LV, Veiko NN An extracellular DNA mediated bystander effect produced from low dose irradiated endothelial cells. Mutat Res 2011; 712: 1-10; PMID: 21392514; http://dx.doi.org/10.1016/j.mrfmmm.2011.03.002
21. Ermakov AV, Konkova MS, Kostyuk SV, Egolina NA, Efremova LV, Veiko NN. Oxidative stress as a significant factor for development of an adaptive response in irradiated and nonirradiated human lymphocytes after inducing the bystander effect by low-dose X-radiation. Mutat Res 2009; 669: 155-61; PMID: 19540246; http://dx.doi.org/10.1016/j.mrfmmm.2009.06.005
22. Olive PL, Wlodek D. Banáth JP. DNA doublestrand breaks measured in individual cells subjected to gel electrophoresis. Cancer Res 1991; 51: 4671-6; PMID: 1873812
23. Rojas E, Lopez MC, Valverde M. Single cell gel electrophoresis assay: methodology and applications. J Chromatogr B Biomed Sci Appl 1999; 722: 225-54; PMID: 10068143; http://dx.doi.org/10.1016/S0378-4347(98)00313-2
24. Ihrke G, Neufeld EB, Meads T, Shanks MR, Cassio D, Laurent M, Schroer TA, Pagano RE, Hubbard AL. WIF-B cells: an in vitro model for studies of hepatocytepolarity. J Cell Biol 1993; 123: 1761-75; PMID: 7506266; http://dx.doi.org/10.1083/jcb.123.6.1761
25. Mersch-Sundermann V, Knasmüller S, Wu XJ, Darroudi F, Kassie F. Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology 2004; 198: 329-40; PMID: 15138059; http://dx.doi.org/10.1016/j.tox.2004.02.009
26. Likhacheva AS, Nikolin VP, Popova NA, Rogachev VA, Prokhorovich MA, Sebeleva TE, Bogachev SS, Shurdov MA. Exogenous DNA can be captured by stem cells and be involved in their rescue from death after lethal-dose γ-radiation. Gene Ther Mol Biol 2007; 11: 305-14
27. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006; 1: 119-50; PMID: 18039110; http://dx.doi.org/10.1146/annurev.pathol.1.110304.100224
28. Vermeulen L, De Sousa E Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-76; PMID: 20418870; http://dx.doi.org/10.1038/ncb2048
29. McMillin DW, Negri JM, Mitsiades CS. The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov 2013; 12: 217-28; PMID: 23449307; http://dx.doi.org/10.1038/nrd3870
30. De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol 2000; 20: 7980-90; PMID: 11027268; http://dx.doi.org/10.1128/MCB.20.21.7980-7990.2000
31. Tronov VA, Kramarenko II, Karpukhin AV. [Colorectal cancer: mismatch repair deficiency, genomic instability, tolerance to apoptosis and assessment of risk] [In Russian]. Vopr On kol 2005; 51: 159-66; PMID: 16222994
32. Storici F, Bebenek K, Kunkel TA, Gordenin DA, Resnick MA. RNA-templated DNA repair. Nature 2007; 447: 338-41; PMID: 17429354; http://dx.doi.org/10.1038/nature05720
33. Insan MB, Jaitak V. New approaches to target cancer stem cells: current scenario. Mini Rev Med Chem 2014; 14: 20-34; PMID: 24195662; http://dx.doi.org/10.2174/13895575113136660107
34. Ebben JD, Treisman DM, Zorniak M, Kutty RG, Clark PA, Kuo JS. The cancer stem cell paradigm: a new understanding of tumor development and treatment. Expert Opin Ther Targets 2010; 14: 621-32; PMID: 20426697; http://dx.doi.org/10.1517/14712598.2010.485186